Factor VIII-related properties in platelets from patients with von Willebrand's disease. 1978

Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin
D014842 von Willebrand Diseases Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion. Angiohemophilia,Hemophilia, Vascular,von Willebrand Disease,Vascular Pseudohemophilia,Von Willebrand Disorder,Von Willebrand's Factor Deficiency,von Willebrand Disease, Recessive Form,von Willebrand's Disease,von Willebrand's Diseases,Angiohemophilias,Disorder, Von Willebrand,Pseudohemophilia, Vascular,Pseudohemophilias, Vascular,Vascular Hemophilia,Vascular Hemophilias,Vascular Pseudohemophilias

Related Publications

Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
July 1977, Thrombosis research,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
June 1977, The New England journal of medicine,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
August 1982, Blood,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
October 1975, Nature,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
June 1976, Haematologica,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
November 1975, Thrombosis et diathesis haemorrhagica,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
June 1990, Clinical pediatrics,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
February 1984, Thrombosis research,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
August 1974, Thrombosis research,
Z M Ruggeri, and P M Mannucci, and R Bader, and T Barbui
October 1974, Lancet (London, England),
Copied contents to your clipboard!